Journal articleMol Cancer Ther2011
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells.
- Journal
- Mol Cancer Ther
- Published
- 30 August 2011
- Citations
- 55
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
A major problem in the treatment of cancer arises from quiescent cancer cells that are relatively insensitive to most chemotherapeutic drugs and radiation. Such residual cancer cells can cause tumor regrowth or recurrence when they reenter the cell cycle. … Excerpt only: this text is the publisher’s. Read it in full at the source.